🔗 Share this article

An underground market for unapproved weight-loss drugs is propelled by TikTok fitness influencers and sellers on communication apps, based on recent findings.

Investigational Drug Acquiring Popularity Via Social Media

Retatrutide, which remains in clinical trials, is being promoted by social media influencers for its alleged fat-burning effects. Followers are encouraged to message these accounts privately for source information, while also receiving promotional offers.

Active Trade on Social Networks

Additionally, a flourishing market exists on messaging services, where groups with thousands of members share comparison photos, administration instructions and claims of next-day British shipping. Vendors market the drug there before directing buyers to other platforms for transactions.

Understanding Retatrutide

Retatrutide is an experimental injectable created by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – GLP-1, GIP and glucagon. Preliminary studies suggest it could help individuals lose up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being promoted digitally as the successor to Ozempic.

Healthcare Professionals Express Concerns

Nevertheless, physicians and chemists have warned that the distribution of what remains an unapproved drug in the United Kingdom is worrisome and could result in individuals injecting products of unknown origin.

Some experts said the demand for the experimental drug could be connected to the increasing price of licensed weight loss treatments such as Mounjaro.

Regulatory Position and Enforcement

Marketing retatrutide on social media or messaging apps is illegal in the United Kingdom, as it is an unapproved medication that cannot be marketed or distributed for human use under the British medical regulations.

Several influencers attempt to sidestep the regulations by referring to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled drug, but promotion and supply can still breach medicines, marketing, and customer regulations, risking fines, prosecution or prison.

Service Response and Content Elimination

According to the social media company, the service has removed problematic content and prohibited related keywords and search suggestions. The organization said it was committed to keeping the platform secure and allocating resources in enhancing enforcement strategies.

Online Marketplace Activities

Investigations also discovered communities with up to nine thousand members selling the experimental drug using Telegram's integrated search feature, which operates like a public directory. Entering “retatrutide” immediately brings up channels with thousands of users, populated with photos of weight loss, glowing testimonials and detailed instructions for preparing or injecting at residence.

After minutes of joining one group, a vendor posted WhatsApp details, where the majority of transactions take place. The seller provided an guidebook and guaranteed delivery within two days. When questioned whether the product was authentic, one seller responded: “You can’t be sure.” Another provided a image of a supposed testing documentation. None inquired about weight, health issues or previous experience.

Item Information and Costs

Inside these groups, messages display black plastic packages with postal service labels, stating to contain new batches. One communication read: “It took eight of us to load them this morning.”

Customers can select between powder vials, mixed at residence with sterile water, or pre-filled injectors typically priced at 160 pounds for 20mg. When asked how long a pen should be used, sellers give conflicting responses ranging from a few weeks to “depends on your body”.

Platform Oversight and Safety Measures

A spokesperson for the messaging service stated it regularly moderated dangerous content on its platform including material that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“Individuals are injecting materials they cannot confirm. Although the science behind retatrutide is sound, these digital products may not include what they claim,” said a pharmacy expert, the director of pharmacy at a pharmacy service.

A medical professional of Asda Online Doctor linked the increase in demand to current price rises for approved weight-loss drugs such as Mounjaro. “With costs increasing, individuals are using social media. But counterfeit treatments are extremely risky. You can’t be certain what’s contained or whether the environment they were made in was sterile,” she explained.

Her staff has already encountered individuals injured by personal administration from unverified suppliers. “We understand the disappointment, but purchasing from Telegram or WhatsApp is taking chances with your health,” stated the doctor. “These materials could be impure or improperly measured.”

Producer Statement

A spokesperson from the pharmaceutical company stated retatrutide was in phase 3 clinical trials and had not been reviewed or approved by any regulatory agency globally. “Consequently at this time no one can sell [it] for human use,” they explained, noting that any product “misleadingly claiming itself as a Lilly investigational product not yet approved … may subject users to potentially significant health risks”.